Investigators at the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins Bloomberg School of Public Health have identified a…
Read More
New Therapies Usher in Era of Personalised Treatment for Rare Blood Cancers
A significant advancement in the treatment of rare blood cancers is set to transform the lives of approximately 200 patients…
Read More
How CTF is trying to rescue pharma’s shelved rare disease drugs
More than 5,000 potential treatments for rare diseases are currently languishing on pharmaceutical company shelves, representing a vast, untapped reservoir…
Read More
A Rare Fossil Goose Discovery Rewrites the Evolutionary Narrative of New Zealand’s Avian Life
A groundbreaking discovery in the ancient lakebed sediments of Central Otago, New Zealand, has unearthed a fossil goose species previously…
Read More
Scientists Uncover How Gene Fusion Droplets Drive Rare Kidney Cancer Progression and Potential New Therapeutic Targets
In a significant breakthrough for oncology and molecular biology, a multidisciplinary team of investigators at the Johns Hopkins Kimmel Cancer…
Read More
How CTF is trying to rescue pharma’s shelved rare disease drugs
More than 5,000 potential treatments for rare diseases are currently languishing on pharmaceutical company shelves, representing a vast, untapped reservoir…
Read More
A Rare Fossil Goose Discovery in Ancient Lakebed Rewrites New Zealand’s Avian Evolutionary History
The discovery of a previously unknown species of fossil goose, unearthed from the ancient lakebed sediments of Central Otago, is…
Read More
Johns Hopkins Researchers Uncover Molecular Mechanism Driving Rare Kidney Cancer Progression through Liquid Protein Droplets
In a significant advancement for the field of precision oncology, a multidisciplinary team of investigators from the Johns Hopkins Kimmel…
Read More
Ipsen Acquires Rare Disease Specialist Memo Therapeutics for up to €700 Million, Bolstering Pipeline with Promising BK Polyomavirus Asset
Paris, France – In a significant strategic move to expand its rare disease portfolio, global biopharmaceutical company Ipsen announced today…
Read More
How CTF is trying to rescue pharma’s shelved rare disease drugs
More than 5,000 potentially life-changing treatments for rare diseases are currently languishing on the shelves of pharmaceutical companies, dormant and…
Read MoreYOU MAY HAVE MISSED
